Skip to content

Advertisement

  • Study protocol
  • Open Access
  • Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

DRAPA trial – closed-suction drains versus closed gravity drains in pancreatic surgery: study protocol for a randomized controlled trial

  • 1Email author,
  • 2,
  • 1,
  • 2,
  • 1, 3 and
  • 1
Trials201516:207

https://doi.org/10.1186/s13063-015-0706-1

Received: 3 October 2014

Accepted: 7 April 2015

Published: 7 May 2015

Abstract

Background

The morbidity of pancreatic resection remains high, with pancreatic fistula being the most common cause. The important question is whether any postoperative treatment adjustment may prevent the development of clinically significant postoperative pancreatic fistulae. Recent studies have shown that intraabdominal drains and manipulation using them are of great importance. Although authors of a few retrospective reports have described good results of pancreatic resection without the use of intraabdominal drains, a recent prospective randomized trial showed that routine elimination of drains in pancreaticoduodenectomy is associated with poor outcome. An important issue arises as to which type of drain is most suitable for pancreatic resection. Two types of surgical drains exist: open drains and closed drains. Open drains are considered obsolete nowadays because of frequent retrograde infection. Closed drains include two types: passive gravity drains and closed-suction drains. Closed-suction drains are more effective, as they remove fluid from the abdominal cavity under light pressure. However, some surgeons believe that closed-suction drains represent a potential hazard to patients and that negative pressure might increase the risk of pancreatic fistulae. Nobody has yet specifically dealt with the question of which kind of drainage is most appropriate in pancreatic surgery.

Methods/Design

The aim of the DRAins in PAncreatic surgery (DRAPA) trial is to compare the closed-suction drain versus the closed passive gravity drain in pancreatic resection. DRAPA is a dual-centre, prospective, randomized controlled trial. The primary endpoint is the rate of postoperative pancreatic fistula; the secondary endpoint is postoperative morbidity with follow-up of 3 months.

Discussion

No study to date has compared different types of drains in pancreatic surgery. This study is designed to answer the question whether any particular type of drain might lower the rate of postoperative pancreatic fistula or other complications.

Trial registration

ClinicalTrials.gov Identifier: NCT01988519. Registered 13 November 2013.

Keywords

  • Closed-suction drain
  • Distal pancreatectomy
  • Pancreatic fistula
  • Pancreaticoduodenectomy
  • Passive gravity drain

Background

Pancreatic resection is the only potentially curative method for treatment of pancreatic neoplasms. These surgical procedures are technically demanding, with pancreaticoduodenectomy and distal pancreatectomy being the most common [1]. Although the mortality rate associated with these procedures has dropped to under 5% in recent decades, the morbidity remains high [2,3]. The most significant and ominous complication is the postoperative pancreatic fistula (POPF) [4]. Although this complication is in most cases not life-threatening, it prolongs the hospital stay and requires additional treatment (for example with antibiotics, nutritional support) and interventions (such as endoscopy, interventional radiology and/or reoperation) and thus increases the cost of the treatment [2,5]. According to the International Study Group of Pancreatic Fistula (ISGPF) consensus definition, pancreatic fistula is diagnosed if the amylase content in fluid from the intraabdominal drains exceeds three times the normal serum concentration [6].

Several methods have been studied in the past with the goal of lowering the pancreatic fistula rate. They include pharmacological prophylaxis with octreotide [7] and various technical modifications of pancreatic remnant management after pancreaticoduodenectomy [8,9] and after distal pancreatectomy [10]. However, the use of octreotide remains controversial, and none of the studied techniques proved to be superior.

Another method of influencing the rate of pancreatic fistulae and postoperative complications is the use of intraabdominal drains and manipulation with them. Recent studies show that the use of drains, the type of drain and the manipulation with the drain can lower the pancreatic fistula rate [11-13].

Intraabdominal drains have traditionally been used in surgical fields [14]. The main significance of the drains is to prevent formation of intraabdominal fluid collection; furthermore, it helps with early diagnosis of postoperative bleeding, pancreatic and biliary leak, or anastomotic dehiscence [15-17]. In some cases, keeping the drain in place for a longer period of time can be part of conservative treatment of the pancreatic fistula, such as by creating a controlled pancreaticocutaneous fistula until the fistula has healed spontaneously without any additional treatment [11,18].

Recent studies show that the use of drains might not be beneficial for the patient, such as in cholecystectomy, appendicectomy, gastric resection, bowel resection and liver resection [19]. Moreover, the use of drains might even be harmful for the patient, as it can slow down recovery and the restoration of bowel movements and can prolong the hospital stay or even cause postoperative complications such as retrograde intraabdominal infection, hollow organ perforation and/or loss of fluid and electrolytes.

Pancreatic surgery is different from surgery of hollow organs. Unlike enteric anastomotic dehiscence, which often presents with pneumoperitoneum and frequently causes peritonitis [20], pancreatic leak is more frequent, but the clinical course is not usually so dramatic [4]. Pancreatic leak or pancreatic fistulae can be easily diagnosed by analysing the amylase concentration in the drain effluent [21]. However, the amylase concentration is increased in the majority of patients on the first postoperative day, even in those patients who do not develop pancreatic fistulae in the postoperative course. This means that the pancreatic anastomosis is not ‘watertight’ in the majority of the patients [22].

The important question is whether any treatment adjustment in the postoperative course may prevent the development of clinically significant POPF. Recent studies have shown that intraabdominal drains and the manipulation with them are of great importance [11,13,23]. Three important questions arise when studying drains in pancreatic surgery:
  1. 1.

    Is it necessary to use drains following pancreatic resection?

     
  2. 2.

    When should the drains be removed?

     
  3. 3.

    Which type of intraabdominal drain is most suitable?

     

These questions are addressed in turn in the subsections below.

Is it necessary to use drains following pancreatic resection?

Drains have traditionally been used in abdominal surgery in most procedures, including pancreatic resection. The first pilot study describing the results of pancreaticoduodenectomy in 22 patients without drains was published in 1992 [24]. A number of retrospective cohort studies have shown superior results of pancreatic resection without routine intraabdominal drainage [13], but only two randomized studies compared pancreatic resection with versus without drains. The first randomized controlled trial was conducted in Memorial Sloan Kettering Cancer Center in New York City [14]. It failed to show that surgically placed intraabdominal drains reduce the rate of complications.

In a recent study, Van Buren et al. showed level I evidence that elimination of routine drainage in all cases of pancreaticoduodenectomy results in unacceptably poor outcomes, and thus this approach cannot be recommended [25]. Further studies are needed to confirm these results.

When should the drains be removed?

Two studies have addressed this question. In one retrospective study, researchers compared removal of the drains on day 4 versus day 8 [26]; in the other, investigators in a prospective randomized trial compared removal of drains on day 3 versus after day 5 in patients with low risk of POPF [15]. Both studies showed a lower rate of intraabdominal complications and fluid collections, and a lower rate of POPF, in the group with early drain removal.

Which type of intraabdominal drain is most suitable?

The final issue regarding drains in pancreatic surgery is which type of drain to use. Two types of surgical drains exist: open drains and closed drains. Open drains are considered obsolete because their use is associated with frequent retrograde infection [27]. Closed drains include two types: passive gravity drains and closed-suction drains. Generally speaking, closed-suction drains are preferred in the United States [28,29], and passive gravity drains are used more frequently in Europe [30]. Only two studies have compared the different types of drains: the Penrose drain versus closed-suction drain [31,32]. However, these two studies were retrospective and conducted over a long period of time (17 years and 22 years, respectively); comparison of the drains was not the primary endpoint; and the studies’ results are contradictory. Nobody has specifically dealt with the question of which kind of drainage is more appropriate in pancreatic surgery [12]. Diener et al., in a systematic review of the current state of evidence for drains in pancreatic surgery, stated that the role of different types of drains remains unclear [11].

Methods/Design

Objectives and hypothesis

The aim of the DRAins in PAncreatic surgery (DRAPA) trial is to compare two types of intraabdominal drains in pancreatic resection and their effect on the development of POPF and postoperative complications. Closed-suction drains are more effective, as they remove fluid from the abdominal cavity under light negative pressure [13]. However, some surgeons believe that closed-suction drains represent a potential hazard to patients [33] and that negative pressure might increase the risk of POPF [13].

The following hypotheses will be tested:
  • H0: The risk of development of POPF and postoperative complications is equal in both groups.

  • H1: The risk of development of POPF and postoperative complications is different between the groups.

Study population and eligibility criteria

The DRAPA trial will encompass two participating centres: University Hospital Hradec Králové and University Hospital Olomouc, both in the Czech Republic. All patients who are scheduled for pancreatic resection at the two participating centres will be screened and assessed for eligibility.

Only patients who undergo pancreaticoduodenectomy or distal pancreatic resection will be included in the study. Patients with nonstandard procedures or a procedure associated with higher morbidity will be excluded from the study to achieve a homogeneous study group. Detailed inclusion and exclusion criteria are described below.

Inclusion criteria

  1. 1.

    Patients scheduled for primary pancreaticoduodenectomy or distal pancreatic resection in participating centres

     
  2. 2.

    Aged 18 years or older

     
  3. 3.

    Signed informed consent provided

     

Exclusion criteria

  1. 1.

    No pancreatic resection performed: nonresectable tumour

     
  2. 2.

    Total pancreatectomy, central pancreatectomy or enucleation

     
  3. 3.

    Multivisceral resection

     
  4. 4.

    Laparoscopic procedure

     
  5. 5.

    Resection of the portal vein and reconstruction with a graft

     
  6. 6.

    Lack of compliance, informed consent not provided or refusal to participate

     

Sample size calculation

The sample size calculation is based on the expected rate of POPF from our previous experience, as there exist no pilot data comparing the closed-suction drain and closed passive gravity drain in pancreatic surgery. The POPF rate in the closed passive gravity drain group is expected to be 35% based on previous studies [2,3]. The POPF rate in the closed-suction drain group is expected to drop to half that rate (17.5%). The sample size calculation is based on a one-sided t-test for differences with respect to the primary endpoint, which is the POPF rate. With α= 5% and β = 20%, a sample size of 97 patients per group is necessary to detect a difference between the groups. With an expected dropout rate of 15%, we plan to enrol 223 patients into the study.

Ethics, study registration and consent

This trial was approved by independent ethics committees at both participating institutions: the University Hospital Hradec Králové (registration number 201308 S27P) and the University Hospital Olomouc (registration number 129/13). The DRAPA trial will be conducted in the context of Good Clinical Practice and in accordance with the Declaration of Helsinki. The trial is registered at ClinicalTrials.gov under the registration number NCT01988519. All patients who are scheduled for pancreatic resection in participating institutions will be screened for eligibility and informed in detail about the DRAPA trial. Informed consent will be obtained from each participant. The study procedures, risks, benefits and data management will be clarified with the patients before they are asked to give their informed consent to participate.

Study treatment

The surgical technique is standardized in both participating institutions and has been described previously [2]. Standard resection of the pancreatic head with duodenum is performed, followed by the reconstruction phase. A jejunum limb is prepared and brought through the transverse mesocolon for the pancreatic and biliary anastomosis. Pancreaticojejunostomy is performed in end-to-side fashion. No stents are used. No additional manipulation, such as fibrin glue or reinforcement with meshes, is allowed. The end-to-side hepaticojejunostomy is made in a single layer of interrupted stitches about 15 cm distal from the pancreaticojejunostomy. End-to-side duodenojejunostomy is performed about 50 cm distally in the antecolic position. For distal pancreatectomy, after exploration of the abdominal cavity, the pancreas is exposed and transected by scalpel in a fish mouth fashion. A splenectomy is performed according to the surgeon’s discretion based on the benign or malignant nature of the tumour. The main pancreatic duct is occluded with a crossing stitch. The pancreatic remnant is then closed with interrupted stitches. In pancreaticoduodenectomy, two drains are placed: one in front of and one behind the pancreatic anastomosis. In distal pancreatectomy, one drain is placed near the pancreatic remnant. A second drain is placed in the left subphrenic area only when splenectomy is performed.

In patients assigned to the closed passive gravity drainage group, passive tube drains (pfm medical, Cologne, Germany) are used. In patients assigned to the closed-suction drain group, BLAKE silicone drains (Ethicon Endo-Surgery, Cincinnati, OH, USA) are used. Drains are pulled through a separate stab incision outside the laparotomy and fixed with a stitch to the skin. The volume of the fluid is measured every 24 hours and noted in the patient’s record form. Amylase content in the drain fluid is analysed every other day starting on the third postoperative day until removal of the drain. Drains are removed between day 4 and day 6 after the surgery if no POPF develops.

Safety aspects

Pancreatic resection is a highly technically demanding procedure. High-volume surgeons with great experience have better results than low-volume surgeons with less experience [34]. In order to avoid bias based on the learning curve of the surgeons, every surgical procedure will be performed or supervised by a senior surgeon who has experience with at least 50 pancreatic resections. Insertion of both types of drain is a simple common procedure performed on a routine basis, and no special training is necessary and no complications are expected.

Postoperative data collection

A daily visit of the study patients will be made by clinical investigators or a delegated physician. All protocol-required information collected during the trial will be entered into the patient’s record form. Preoperative data gathered include patient sex, age, body mass index, American Society of Anesthesiologists physical status classification system score and comorbidities, especially those considered to increase the risk of POPF (diabetes mellitus and ischaemic heart disease) [35,36]. Intraoperative data to be collected include surgery duration, estimated blood loss, diameter of the main pancreatic duct and pancreatic gland texture. The diameter of the main pancreatic duct will be measured with a set of probes. Postoperative data to be gathered include volume of the drain output measured every 24 hours, amylase content analysed every other day starting on day 3, and the day of drain removal. Laboratory tests will include serum amylase, C-reactive protein, bilirubin and leukocyte count on days 3 and 7 [37]. Postoperative course assessments will include duration of intensive care, hospital stay including readmissions for postoperative complications, reinterventions (reoperations, endoscopy and interventional radiology procedures) and the reasons for readmissions. All the patients will have undergo ultrasonography or computed tomography (CT) before discharge from the hospital to detect any fluid collections. The patients will be seen by a clinical investigator 6 weeks and 3 months after the surgery in the outpatient department.

Primary and secondary endpoints

The primary endpoint of this study is the rate of POPF occurrence. POPF is defined by the ISGPF as any measurable volume of drain fluid on or after postoperative day 3 with amylase content greater than three times the normal upper serum value [6]. Three grades of POPF are determined according to clinical severity: A, B and C.

Grade A POPF, also called ‘transient fistula’, has no clinical impact. The patient’s clinical condition is good, and little or no change in clinical management is required. Hospital discharge is not delayed. The drains are usually removed within 3 weeks.

Grade B POPF is symptomatic and clinically apparent, and peripancreatic collections may occur. Changes in clinical management are required, such as nutritional support, as well as antibiotics in cases of infection, and new drains into the collections may be inserted. Hospital stay is usually delayed, or readmission may be required.

Grade C POPF is severe and clinically significant. The clinical condition of the patient is poor, and stability may be borderline. Major changes in clinical management are required, such as intensive care, CT-guided drainage of peripancreatic collections or reoperation.

The secondary endpoint is the postoperative morbidity, including wound infection, intraabdominal collections, delayed gastric emptying, postoperative haemorrhage, pneumonia, abdominal rupture, cardiac events and neurological complications (Table 1), as previously defined [5,30,38-41]. Postoperative complications are graded based on severity according to the Clavien-Dindo definition as modified by DeOliveira and colleagues for pancreatic surgery [42,43] (Table 2).
Table 1

Clinical parameters and postoperative complications for analysis a

Parameters

Definitions

Hospital stay

Days from initial operation to hospital discharge plus any readmission within 30 days

Operating time

Time from skin incision to wound closure (minutes)

Delayed gastric emptying

Failure to resume solid diet with prolonged need for nasogastric tube as defined by ISGPS [40]

Biliary leak

Bilirubin concentration in the drain fluid at least three times the serum bilirubin concentration as defined by ISGLS [38]

Postoperative haemorrhage

Evidence of blood loss from drains and/or nasogastric tube, based on ultrasonography, as defined by ISGPS [41]

Intraabdominal fluid collection

Collection of fluid measuring ≥3 cm associated with clinical or laboratory abnormalities

Symptomatic fluidothorax

Fluid in the pleural cavity associated with respiratory distress or a need to evacuate the fluid

Abdominal rupture

Dehiscence of abdominal closure with need for resuture of the laparotomy during the initial hospital stay

Myocardial infarction

Increase of serum concentration of CK-MB and troponin and/or the following ECG changes: new Q waves ≥0.04 in duration, new persistent ST elevation and/or depression

Pneumonia

Presence of a new infiltrate on chest X-ray, as well as the following: body temperature >38°C, abnormal elevation of WBC, or positive sputum, and requiring antibiotic treatment

Acute renal failure

Serum creatinine >3.0 mg/dl and/or need for dialysis

Wound infection

Surgical site infection associated with laparotomy that develops during the initial hospital stay

Urinary tract infection

Culture-positive urine, pyuria or bacteriuria on urinalysis requiring antibiotic treatment

aCK-MB, Creatine kinase MB isoenzyme; ECG, Electrocardiogram; ISGLS, International Study Group of Liver Surgery; ISGPS, International Study Group for Pancreatic Surgery; WBC, White blood cells.

Table 2

Complication grades according to the Dindo-DeOliveira classification scheme a

Grade

Definition

Grade I

Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiologic intervention

Grade II

Requiring pharmacological treatment with drugs other than those allowed for grade I complications

Grade III

Requiring surgical, endoscopic or radiological intervention

Grade IIIa

Intervention not under general anaesthesia

Grade IIIb

Intervention under general anaesthesia

Grade IV

Life-threatening complications requiring intensive care unit management

Grade IVa

Single-organ dysfunction

Grade IVb

Multiorgan dysfunction

Grade V

Death of patient

aThe Dindo-DeOliveira classification system is reported in detail elsewhere [42,43].

Methods for avoiding bias

Minimizing systemic bias

Patients will be randomized to one of the drain groups during the surgical procedure after resectability of the tumour is confirmed. Randomization will be accomplished using balanced permutation blocks by generation of random numbers in order to obtain homogeneity between groups. Patients scheduled for pancreaticoduodenectomy and distal pancreatectomy will be randomized separately, as these two procedures are different with regard to the course and consequences of POPF [25,44]. Opaque, sealed envelopes will be produced, labelled with the randomization number and containing a sheet that states the group allocation for the patient. Randomization envelopes will be used in consecutive order. Basic characteristics of the patient and the day of randomization will be documented on a data sheet so that compliance to the randomization scheme may be checked retrospectively. If patients are excluded from the study after randomization, their numbers will not be reused. Obviously, operating surgeons, attending physicians and nursing staff cannot be blinded, as the drains look different. However, outcome assessors will be blinded. The randomization process will follow the CONSORT guidelines (Figure 1) [45].
Figure 1
Figure 1

Flowchart of the process of the phases of the randomized trial according to the CONSORT guidelines.

Minimizing treatment bias

Pancreatic resection is standardized in both participating centres. Both types of drain are used in the participating departments; all surgeons participating in the study are familiar with them. Insertion of both types of drain is a simple, common procedure performed on a routine basis, which eliminates a learning curve.

Minimizing measurement bias

Detection and grading of POPF and postoperative complications, which are the primary and secondary endpoints, will be based on data in the patient’s record form. Blinding is not necessary, because the occurrence of POPF is an objective endpoint that cannot be influenced by the patient. Physician blinding is not possible, because the drains are apparently different.

Statistical methods

Each patient’s allocation to the analysed population will be defined prior to the analysis and will be documented. In the full-analysis set, patients will be analysed as randomized according to the intention-to-treat principle. The intention-to-treat principle implies that the analysis includes all randomized patients. The per-protocol analysis set will include all the patients without major protocol deviation. Deviations from the protocol will be assessed as major or minor. Patients with major deviations from the protocol will be excluded from the per-protocol analysis. The safety analysis set will analyse patients according to the treatment.

The null hypothesis assumes that the risk of development of POPF and postoperative complications is equal in both groups. A binary logistic regression will be applied in order to compare POPF in the groups adjusting for other factors. Two-tailed t-tests or nonparametric Mann–Whitney U tests will be applied for continuous secondary endpoints. χ2 tests or Fisher’s exact test will be used for analysis of categorical secondary endpoints. A P-value <0.05 will be considered statistically significant. Statistical analyses will be performed using NCSS statistical software (NCSS, Kaysville, UT, USA).

Discussion

Despite growing evidence in favour of pancreatic resection without intraabdominal drainage [13], routine elimination of drains cannot be recommended [25]. Rather more, drains could diminish the rate and severity of POPF in patients with high risk of POPF. Drains could possibly be avoided in patients with low risk of POPF [46]. However, the majority of pancreatic surgeons still consider routine placement of intraabdominal drains mandatory [15-17]. Once a decision is made to use intraabdominal drains, a controversy remains about which type of drain is most suitable in pancreatic resection [47]. Two types of drains are commonly used nowadays: passive gravity drains [26,30] and closed-suction drains [28,29]. Closed-suction drains are more effective, as they remove fluid from the abdominal cavity under light negative pressure [13]. However, some surgeons believe that closed-suction drains represent a potential hazard to patients [33] and that negative pressure might increase the risk of POPF [13]. No study conducted to date has specifically addressed the question of which type of drain is most beneficial for patients [12,13].

The DRAPA trial is designed to compare closed-suction drains with passive gravity drains in pancreatic surgery. Using the ISGPF definition of POPF will allow us to compare the results of this trial with those of other trials of drains in pancreatic surgery. This trial can show whether closed-suction drains represent hazards to patients or are beneficial in terms of decreasing POPF rates.

Trial status

The DRAPA trial is currently recruiting patients. The last patient is expected to be recruited by December 2015.

Abbreviations

CK-MB: 

Creatine kinase MB fraction

CONSORT: 

Consolidated Standards of Reporting Trials

DRAPA: 

DRAins in PAncreatic surgery trial

ECG: 

Electrocardiogram

ISGLS: 

International Study Group of Liver Surgery

ISGPF: 

International Study Group of Pancreatic Fistula

ISGPS: 

International Study Group of Pancreatic Surgery

POPF: 

Postoperative pancreatic fistula

WBC: 

White blood cells

Declarations

Acknowledgements

We thank the teams in the Department of Surgery at the University Hospital Hradec Králové, Czech Republic, and the Department of Surgery at the University Hospital Olomouc, Czech Republic, for their support. We thank Dr Eva Čermáková of the Departments of Medical Biophysics and Biostatistics, Faculty of Medicine, Charles University in Prague, Hradec Králové, Czech Republic, for planned statistical analyses. We also thank all of the patients who are participating in this trial. This project was supported by a grant from the Czech Republic Ministry of Health MH CZ-DRO project (University Hospital Hradec Kralove (UHHK), 00179906). The authors are grateful to Ian McColl, MD, PhD, for assistance with the manuscript.

Authors’ Affiliations

(1)
Department of Surgery, Faculty of Medicine, University Hospital Hradec Králové, Hradec Králové, Czech Republic
(2)
First Department of Surgery, Faculty of Medicine, University Hospital Olomouc, Olomouc, Czech Republic
(3)
Department of Field Surgery, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic

References

  1. Hartwig W, Werner J, Jäger D, Debus J, Büchler MW. Improvement of surgical results for pancreatic cancer. Lancet Oncol. 2013;14:e476–85.View ArticlePubMedGoogle Scholar
  2. Čečka F, Jon B, Šubrt Z, Ferko A. Clinical and economic consequences of pancreatic fistula after elective pancreatic resection. Hepatobiliary Pancreat Dis Int. 2013;12:533–9.View ArticlePubMedGoogle Scholar
  3. Diener MK, Seiler CM, Rossion I, Kleeff J, Glanemann M, Butturini G, et al. Efficacy of stapler versus hand-sewn closure after distal pancreatectomy (DISPACT): a randomised, controlled multicentre trial. Lancet. 2011;377:1514–22.View ArticlePubMedGoogle Scholar
  4. Butturini G, Daskalaki D, Molinari E, Scopelliti F, Casarotto A, Bassi C. Pancreatic fistula: definition and current problems. J Hepatobiliary Pancreat Surg. 2008;15:247–51.View ArticlePubMedGoogle Scholar
  5. Pratt WB, Maithel SK, Vanounou T, Huang ZS, Callery MP, Vollmer Jr CM. Clinical and economic validation of the International Study Group of Pancreatic Fistula (ISGPF) classification scheme. Ann Surg. 2007;245:443–51.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.View ArticlePubMedGoogle Scholar
  7. Čečka F, Jon B, Šubrt Z, Ferko A. The effect of somatostatin and its analogs in the prevention of pancreatic fistula after elective pancreatic surgery. Eur Surg. 2012;44:99–108.View ArticleGoogle Scholar
  8. Kawai M, Yamaue H. Analysis of clinical trials evaluating complications after pancreaticoduodenectomy: a new era of pancreatic surgery. Surg Today. 2010;40:1011–7.View ArticlePubMedGoogle Scholar
  9. Yang SH, Dou KF, Sharma N, Song WJ. The methods of reconstruction of pancreatic digestive continuity after pancreaticoduodenectomy: a meta-analysis of randomized controlled trials. World J Surg. 2011;35:2290–7.View ArticlePubMedGoogle Scholar
  10. Čečka F, Jon B, Šubrt Z, Ferko A. Surgical technique in distal pancreatectomy: a systematic review of randomized trials. Biomed Res Int. 2014;2014:482906.PubMedPubMed CentralGoogle Scholar
  11. Diener MK, Tadjalli-Mehr K, Wente MN, Kieser M, Büchler MW, Seiler CM. Risk–benefit assessment of closed intra-abdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing the current state of evidence. Langenbecks Arch Surg. 2011;396:41–52.View ArticlePubMedGoogle Scholar
  12. Strobel O, Büchler MW. Drainage after pancreaticoduodenectomy: controversy revitalized. Ann Surg. 2014;259:613–5.View ArticlePubMedGoogle Scholar
  13. Wang Q, Jiang YJ, Li J, Yang F, Di Y, Yao L, et al. Is routine drainage necessary after pancreaticoduodenectomy? World J Gastroenterol. 2014;20:8110–8.View ArticlePubMedPubMed CentralGoogle Scholar
  14. Conlon KC, Labow D, Leung D, Smith A, Jarnagin W, Coit DG, et al. Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg. 2001;234:487–94.View ArticlePubMedPubMed CentralGoogle Scholar
  15. Bassi C, Molinari E, Malleo G, Crippa S, Butturini G, Salvia R, et al. Early versus late drain removal after standard pancreatic resections: results of a prospective randomized trial. Ann Surg. 2010;252:207–14.View ArticlePubMedGoogle Scholar
  16. Büchler MW, Friess H. Evidence forward, drainage on retreat: still we ignore and drain!? Ann Surg. 2006;244:8–9.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Shrikhande SV, Barreto SG, Shetty G, Suradkar K, Bodhankar YD, Shah SB, et al. Post-operative abdominal drainage following major upper gastrointestinal surgery: single drain versus two drains. J Cancer Res Ther. 2013;9:267–71.View ArticlePubMedGoogle Scholar
  18. Balzano G, Zerbi A, Cristallo M, Di Carlo V. The unsolved problem of fistula after left pancreatectomy: the benefit of cautious drain management. J Gastrointest Surg. 2005;9:837–42.View ArticlePubMedGoogle Scholar
  19. Petrowsky H, Demartines N, Rousson V, Clavien PA. Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg. 2004;240:1074–85.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Čečka F, Sotona O, Šubrt Z. How to distinguish between surgical and non-surgical pneumoperitoneum? Signa Vitae. 2014;9(1):1.Google Scholar
  21. Molinari E, Bassi C, Salvia R, Butturini G, Crippa S, Talamini G, et al. Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. Ann Surg. 2007;246:281–7.View ArticlePubMedPubMed CentralGoogle Scholar
  22. Lee CW, Pitt HA, Riall TS, Ronnekleiv-Kelly SS, Israel JS, Leverson GE, et al. Low drain fluid amylase predicts absence of pancreatic fistula following pancreatectomy. J Gastrointest Surg. 2014;18:1902–10.View ArticlePubMedPubMed CentralGoogle Scholar
  23. Giovinazzo F, Butturini G, Salvia R, Mascetta G, Monsellato D, Marchegiani G, et al. Drain management after pancreatic resection: state of the art. J Hepatobiliary Pancreat Sci. 2011;18:779–84.View ArticlePubMedGoogle Scholar
  24. Jeekel J. No abdominal drainage after Whipple’s procedure. Br J Surg. 1992;79:182.View ArticlePubMedGoogle Scholar
  25. Van Buren II G, Bloomston M, Hughes SJ, Winter J, Behrman SW, Zyromski NJ, et al. A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage. Ann Surg. 2014;259:605–12.View ArticlePubMedGoogle Scholar
  26. Kawai M, Tani M, Terasawa H, Ina S, Hirono S, Nishioka R, et al. Early removal of prophylactic drains reduces the risk of intra-abdominal infections in patients with pancreatic head resection: prospective study for 104 consecutive patients. Ann Surg. 2006;244:1–7.View ArticlePubMedPubMed CentralGoogle Scholar
  27. Sarr MG, Parikh KJ, Minken SL, Zuidema GD, Cameron JL. Closed-suction versus Penrose drainage after cholecystectomy: a prospective, randomized evaluation. Am J Surg. 1987;153:394–8.View ArticlePubMedGoogle Scholar
  28. Correa-Gallego C, Brennan MF, D’Angelica M, Fong Y, Dematteo RP, Kingham TP, et al. Operative drainage following pancreatic resection: analysis of 1122 patients resected over 5 years at a single institution. Ann Surg. 2013;258:1051–8.View ArticlePubMedGoogle Scholar
  29. Fisher WE, Hodges SE, Silberfein EJ, Artinyan A, Ahern CH, Jo E, et al. Pancreatic resection without routine intraperitoneal drainage. HPB (Oxford). 2011;13:503–10.View ArticlePubMedPubMed CentralGoogle Scholar
  30. Hassenpflug M, Bruckner T, Knebel P, Diener MK, Büchler MW, Werner J. DISCOVER trial – Distal resection of the pancreas with or without coverage of the pancreatic remnant: study protocol of a randomised controlled trial. Trials. 2013;14:430.View ArticlePubMedPubMed CentralGoogle Scholar
  31. Schmidt CM, Choi J, Powell ES, Yiannoutsos CT, Zyromski NJ, Nakeeb A, et al. Pancreatic fistula following pancreaticoduodenectomy: clinical predictors and patient outcomes. HPB Surg. 2009;2009:404520.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Yoshikawa K, Konishi M, Takahashi S, Gotohda N, Kato Y, Kinoshita T. Surgical management for the reduction of postoperative hospital stay following distal pancreatectomy. Hepatogastroenterology. 2011;58:1389–93.View ArticlePubMedGoogle Scholar
  33. Grobmyer SR, Graham D, Brennan MF, Coit D. High-pressure gradients generated by closed-suction surgical drainage systems. Surg Infect (Larchmt). 2002;3:245–9.View ArticlePubMedGoogle Scholar
  34. Schmidt CM, Turrini O, Parikh P, House MG, Zyromski NJ, Nakeeb A, et al. Effect of hospital volume, surgeon experience, and surgeon volume on patient outcomes after pancreaticoduodenectomy: a single-institution experience. Arch Surg. 2010;145:634–40.View ArticlePubMedGoogle Scholar
  35. Cheng Q, Zhang B, Zhang Y, Jiang X, Zhang B, Yi B, et al. Predictive factors for complications after pancreaticoduodenectomy. J Surg Res. 2007;139:22–9.View ArticlePubMedGoogle Scholar
  36. Lin JW, Cameron JL, Yeo CJ, Riall TS, Lillemoe KD. Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula. J Gastrointest Surg. 2004;8:951–9.View ArticlePubMedGoogle Scholar
  37. Hiyoshi M, Chijiiwa K, Fujii Y, Imamura N, Nagano M, Ohuchida J. Usefulness of drain amylase, serum C-reactive protein levels and body temperature to predict postoperative pancreatic fistula after pancreaticoduodenectomy. World J Surg. 2013;37:2436–42.View ArticlePubMedGoogle Scholar
  38. Koch M, Garden OJ, Padbury R, Rahbari NN, Adam R, Capussotti L, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery. 2011;149:680–8.View ArticlePubMedGoogle Scholar
  39. Sierzega M, Kulig P, Kolodziejczyk P, Kulig J. Natural history of intra-abdominal fluid collections following pancreatic surgery. J Gastrointest Surg. 2013;17:1406–13.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142:761–8.View ArticlePubMedGoogle Scholar
  41. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery. 2007;142:20–5.View ArticlePubMedGoogle Scholar
  42. DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–9.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Pratt W, Maithel SK, Vanounou T, Callery MP, Vollmer Jr CM. Postoperative pancreatic fistulas are not equivalent after proximal, distal, and central pancreatectomy. J Gastrointest Surg. 2006;10:1264–79.View ArticlePubMedGoogle Scholar
  45. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol. 2001;1:2.View ArticlePubMedPubMed CentralGoogle Scholar
  46. McMillan MT, Fisher WE, Van Buren II G, McElhany A, Bloomston M, Hughes SJ, et al. The value of drains as a fistula mitigation strategy for pancreatoduodenectomy: something for everyone? Results of a randomized prospective multi-institutional study. J Gastrointest Surg. 2015;19:21–31.View ArticlePubMedGoogle Scholar
  47. Rondelli F, Desio M, Vedovati MC, Balzarotti Canger RC, Sanguinetti A, Avenia N, et al. Intra-abdominal drainage after pancreatic resection: Is it really necessary? A meta-analysis of short-term outcomes. Int J Surg. 2014;12 Suppl 1:S40–7.View ArticlePubMedGoogle Scholar

Copyright

© Cecka et al. 2015

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement